Case Reports in Otolaryngology

Case Reports in Otolaryngology / 2016 / Article

Case Report | Open Access

Volume 2016 |Article ID 3065657 |

Ashraf Nabeel Mahmood, Rashid Sheikh, Hamad Al Saey, Sarah Ashkanani, Shanmugam Ganesan, "Angiofibroma Originating outside the Nasopharynx: A Management Dilemma", Case Reports in Otolaryngology, vol. 2016, Article ID 3065657, 4 pages, 2016.

Angiofibroma Originating outside the Nasopharynx: A Management Dilemma

Academic Editor: Holger Sudhoff
Received06 Jul 2016
Revised12 Oct 2016
Accepted23 Oct 2016
Published13 Nov 2016


Background. Angiofibroma is a benign tumor, consisting of fibrous tissue with varying degrees of vascularity, characterized by proliferation of stellate and spindle cells around the blood vessels. It most commonly arises from the nasopharynx, although it may rarely arise in extranasopharyngeal sites. Case Report. A 46-year-old male presented with left side nasal obstruction and epistaxis for one month. Clinical nasal examination revealed left sided polypoidal mass arising from the vestibular region of the lateral nasal wall. Results. CT scan and MRI showed highly vascular soft tissue mass occupying the anterior part of the left nostril. Preoperative selective embolization followed by transnasal excision was performed. Histopathological examination confirmed the diagnoses of nasal vestibular angiofibroma. Conclusion. Extranasopharyngeal angiofibroma is a very rare pathology. It should be kept in mind as a differential diagnosis with any unilateral nasal vestibular mass causing nasal obstruction and epistaxis. A biopsy without further investigation can cause life threatening bleeding in the patient.

1. Introduction

Angiofibroma is a benign tumor, consisting of fibrous tissue with varying degrees of vascularity, characterized by a proliferation of stellate and spindle cells around the blood vessels. It is originating from the pterygoid plate and the region of the sphenopalatine foramen. There are many theories trying to explain the pathology underlying this tumor, like genetic, hormonal, and developmental ones, but none of them had general acceptance. It has been hypothesized that angiofibroma is a testosterone-dependent tumor that arises from a fibrovascular nidus in the nasopharynx that lies dormant until the onset of puberty; hence the incidence is more in males with peak incidence between the ages of 14 and 18 years [1]. Histologically, angiofibroma is made up of fibrous and vascular components, with varying ratio between both of them. Mostly, the vessels are just endothelium-lined spaces without muscle coat, and that accounts for the severe bleeding as the vessels lose the ability to contract [2]. It is the most common vascular neoplasm of the nasal cavity, representing 0.5% of all head and neck tumors [1, 3, 4]. Although it is a benign tumor, it is locally invasive. Progressive nasal obstruction is the most common presenting symptom [5]. Despite the fact that it most commonly arises from the nasopharynx, it may rarely arise in extranasopharyngeal sites, like maxillary sinus which is the most common site (24.6%–32%) [47]. Other rare reported sites include ethmoid and sphenoid sinuses, nasal septum, middle turbinate, inferior turbinate, conjunctiva, molar and retromolar region, and tonsil and larynx [1]. Here, we report a very rare case of extranasopharyngeal angiofibroma originating from the lateral wall of the left nasal vestibular area.

2. Case Report

A 46-year-old male, not known to have any chronic illness, presented to the emergency department in Hamad Medical Corporation due to one-month history of left side intermittent anterior nasal bleeding increasing in severity and associated with nasal blockage. He had a history of decreased sense of smell and headache for one month. There was no history of trauma, infection, nasal allergies, or bleeding disorders. ENT examination showed mildly deviated nasal septum to the right side with a left sided pinkish colored polypoidal mass originating from the vestibular region of the left lateral nasal wall, easily bleeding upon manipulation. Ears and throat examination was normal. Silver nitrate cauterization was done and bleeding was controlled. So the patient was discharged and he was referred to ORL-HNS clinic for follow-up. The white blood cells count (WBC) was 8.8 × 103/mm3, hemoglobin (Hb) level 12.5 g/100 mL, and platelets count (Plt) 278 × 103/mm3. Liver and kidney function tests were normal. CT scan of paranasal sinuses showed 3.4 × 2.5 × 1.9 cm mass localized to the anterior part of the left side of the nasal cavity with no extension to the choana or to the paranasal sinuses (Figures 1(a) and 1(b)). MRI (done to rule out hypervascularity of the mass before surgical intervention) showed a hypervascular mass in the same previously described position (Figures 2(a), 2(b), and 2(c)). 24 hours before the surgery, angiography was done which showed hypervascular left side nasal mass supplied by the distal branches of the left internal maxillary artery and distal branches of the left facial artery. Selective embolization was done, to decrease the intraoperative bleeding, with polyvinyl alcohol temporary occlusive particles (PVA), which reduced 85% of the blood flow to the area (Figures 3(a) and 3(b)).

The removal of the tumor was performed under general anesthesia. The pedicle had been completely transected with bipolar diathermy, with insignificant bleeding which was controlled with electrocautery. Nasal pack was inserted in the left nostril only. The postoperative period was uneventful, and the pack was removed on the third postoperative day with no bleeding, and the patient was discharged on the same day. The mass was sent for histopathology. Immunohistochemical staining was performed for AE1/3, vimentin, SMA, desmin, S-100, CD34, CD31, CD117, CD99 BCL-2, and ki-67. The histomorphology and immunohistochemical staining profile supported the diagnosis of angiofibroma (Figure 4). The patient was followed up in the clinic and clinical examination during his last visit (6 months after surgery) showed no recurrence and clear site of operation.

3. Discussion

The nasal vestibule is lined with keratinizing squamous epithelium and contains different components such as sebaceous glands and sweat glands. So the pathologic lesions in the nasal vestibule are different from those in the nasal cavity proper; they can be infectious, inflammatory, benign, or malignant tumors. Differential diagnoses can include nasal vestibule cyst, fibroma, squamous papilloma, trichofolliculoma, pseudoepitheliomatous hyperplasia, sebaceous cyst carcinoma, hidradenoma, rhinoscleroma, and malignant melanoma [8, 9]. Here we report a case of nasal vestibule angiofibroma, which is the only hypervascular tumor among all the other mentioned diagnoses.

The presenting symptoms of the nasal vestibular angiofibroma are nasal obstruction and epistaxis [2, 3, 5]. The main differences in clinical presentation of extranasopharyngeal angiofibroma (ENA) versus nasopharyngeal angiofibroma (NA) are the sex predilection, age of presentation, and vascularity. With regards to gender predilection, NA is predominantly a disease of males. However, ENA is of a greater incidence relative to NA in females. Also ENA presents in older age group more than NA, with mean age of 22 years and 17 years, respectively [3, 7], while for nasal vestibule angiofibroma the mean age is 43 years. The administration of contrast agent in NA leads to a strong and usually homogeneous enhancement on CT and MRI, while EN varies from strong to minimal or even no enhancement, due to the frequent poor vascularity of the tumor [10].

The management of any vestibular mass should include preoperative radiological examination. CT scan and MRI (with contrast) are essential for evaluating the extension and vascularity of the lesion. However, signs of suspected hypervascularity, upon CT scan or MRI, indicate the need for angiography with selective embolization prior to any surgical intervention, to reduce the risk of bleeding during the surgery. The use of angiography and selective embolization should have a high threshold, that is, only if there is radiological evidence of diffuse, large, and hypervascular lesion, as these procedures come with their own complications. There are three cases of nasal vestibule angiofibroma previously reported in the literature with no preoperative embolization; all had different amount of intraoperative bleeding varying from minimal to profuse (Table 1). Perhaps smaller lesions can be excised without the need for such elaborate perioperative measures like angiography and embolization. However, the diagnosis should be confirmed by sending the excised lesion for histopathology. The NA have a recurrence rate ranging from 6 to 27.5% [7], while no recurrence was reported in the literature for ENA.

AuthorsYearAgeSexLocationSymptomsOnsetTherapyPre-op embolization

Kim et al. [8]201356 yearsFemaleRight nasal vestibuleProgressive swelling3 yearsEndonasal resection (bleeding)No
Pillenahalli Maheshwarappa et al. [1]201310 yearsMaleLeft nasal vestibuleNasal obstruction and epistaxis4 monthsEndoscopic excision (profuse bleeding)No
Sharanabasappa [11]201360 yearsMaleLeft nasal vestibuleNasal mass1 yearTransnasal resection (minimal bleeding)No
Present case201446 yearsMaleLeft nasal vestibuleRecurrent epistaxis and nasal obstruction1 monthTransnasal resection (insignificant bleeding)Yes

4. Conclusion

(1)Although extranasopharyngeal angiofibroma is very rare diagnosis, it should be kept in mind as a differential diagnosis with any unilateral nasal vestibular mass causing nasal obstruction and epistaxis.(2)CT scan and MRI are essential in the preoperative evaluation of a vestibular mass to assess for hypervascularity.(3)The use of angiography and selective embolization should have a high threshold, that is, only if there is radiological evidence of diffuse, large, and hypervascular lesions which are predictive factors of intraoperative profuse bleeding.

Ethical Approval

The case at hand has already been approved by the authors’ institution’s medical research and ethics committee at the research center.

The patient’s consent was taken for the publication of the case report and the figures.

Competing Interests

Authors have no conflict of interests or financial interest, real or perceived, to disclose.


  1. R. Pillenahalli Maheshwarappa, A. Gupta, J. Bansal, M. V. Kattimani, S. S. Shabadi, and S. C. Baser, “An unusual location of juvenile angiofibroma: a case report and review of the literature,” Case Reports in Otolaryngology, vol. 2013, Article ID 175326, 3 pages, 2013. View at: Publisher Site | Google Scholar
  2. P. L. Dhingra and S. Dhingra, Diseases of Ear, Nose & Throat, Elsevier, 5th edition, 2010.
  3. M. Uyar, M. Turanli, I. Pak, S. Bakir, and U. Osma, “Extranasopharyngeal angiofibroma originating from the nasal septum: a case report,” Kulak Burun Boğaz İhtisas Dergisi, vol. 19, no. 1, pp. 41–44, 2009. View at: Google Scholar
  4. S. K. Bhargava and S. Phatak, “Angiofibroma arising from nasal septum in adult male—a rare occurence,” Indian Journal of Otolaryngology and Head and Neck Surgery, vol. 47, no. 1, pp. 39–41, 1995. View at: Publisher Site | Google Scholar
  5. J. A. S. Makhasana, M. A. Kulkarni, S. Vaze, and A. S. Shroff, “Juvenile nasopharyngeal angiofibroma,” Journal of Oral and Maxillofacial Pathology, vol. 20, no. 2, article 330, 2016. View at: Google Scholar
  6. L. Garcia-Rodriguez, K. Rudman, C. H. Cogbill, T. Loehrl, and D. M. Poetker, “Nasal septal angiofibroma, a subclass of extranasopharyngeal angiofibroma,” American Journal of Otolaryngology—Head and Neck Medicine and Surgery, vol. 33, no. 4, pp. 473–476, 2012. View at: Publisher Site | Google Scholar
  7. A. Szymańska, M. Szymański, K. Morshed, E. Czekajska-Chehab, and M. Szczerbo-Trojanowska, “Extranasopharyngeal angiofibroma: clinical and radiological presentation,” European Archives of Oto-Rhino-Laryngology, vol. 270, no. 2, pp. 655–660, 2013. View at: Publisher Site | Google Scholar
  8. S. J. Kim, S. W. Byun, and S.-S. Lee, “Various tumors in the nasal vestibule,” International Journal of Clinical and Experimental Pathology, vol. 6, no. 12, pp. 2713–2718, 2013. View at: Google Scholar
  9. S.-H. Zhou, Y.-Y. Xu, S.-Q. Wang, L. Ling, H.-T. Yao, and G.-P. Ren, “Analysis of 60 masses in the nasal vestibule,” Zhonghua Er Bi Yan Hou Ke Za Zhi, vol. 39, no. 6, pp. 337–339, 2004. View at: Google Scholar
  10. I. Tasca and G. C. Compadretti, “Extranasopharyngeal angiofibroma of nasal septum. A controversial entity,” Acta Otorhinolaryngologica Italica, vol. 28, no. 6, pp. 312–314, 2008. View at: Google Scholar
  11. R. M. Sharanabasappa, “Extranasopharyngeal angiofibroma from nasal vestibule: a rare presentation,” JP Journals, vol. 5, no. 3, pp. 169–172, 2013. View at: Google Scholar

Copyright © 2016 Ashraf Nabeel Mahmood et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Related articles

No related content is available yet for this article.
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

No related content is available yet for this article.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.